Decline in NAD+ availability is tightly linked to many neurological disorders. Our recent study also revealed age dependences of intracellular NAD+, NADH and total NAD concentrations in healthy human brains. Accumulating evidences have shown that the cellular NAD+ could serve as a therapeutic target for treating metabolic or age-related neurological diseases and promoting longevity. Therefore, to investigate the effect of exogenous NAD+ on intracellular NAD metabolism, the in vivo 31P-MRS NAD imaging assay developed in our lab was applied in normal rat brains at 16.4 T. Significant increases of cerebral α-ATP, total NAD and NAD+ levels were observed after the intra-peritoneal infusion of exogenous NAD+. This study not only demonstrates the feasibility of using exogenous NAD+ to enhance cerebral ATP and NAD metabolisms, but also provides an opportunity to better understand the roles of NAD metabolism in health and age-related disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords